Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b8726f713a6d86892687edccfa03d886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ada142a904df54cdb0a4cd77ccfa9c9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_557bb8a6886c3b6d3d3654e0b4163d76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0f1131c08e910adbaae9f3344a269a22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb516bcdd62ca72826bf4e1f9b46cbe0 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6875 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5023 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-567 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate |
2003-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69d5a41e54b8069a39d8ee7bc3362793 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbe3d667c24f1ffda0616de67e05d834 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49d4dff586b6b86aa00bb8d2447dda7f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd7718b6e0f81d9ca39cc2b1936cd755 |
publicationDate |
2004-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2004043370-A2 |
titleOfInvention |
Methods and compositions for modulating activator protein 1 |
abstract |
This invention provides novel AP-1 modulatory polypeptides. The invention also provides methods for screening modulators of AP-1 transcription factor activities. The methods comprise first screening test agents for modulators of an AP-1-modulatory polypeptide and then further screening the identified modulating agents for modulators of AP-1 transcription factor activities. The invention further provides methods and pharmaceutical compositions for modulating AP-1 transcription factor activities in a cell and for treating diseases and conditions mediated by abnormal cellular proliferation. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009053683-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7344833-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009053683-A3 |
priorityDate |
2002-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |